

Hello.
This is Song Sang-hoon from Cheongdam Goldendiamant Plastic Surgery.^^
April has begun,
and warm spring sunshine continues to grace our days.
News of cherry blossoms in full bloom
is already coming from southern cities
like Jeju Island and Busan.

Soon, after the season of cherry blossom petals fluttering
throughout the streets of Seoul passes,
I realize summer will be here in no time,
and I'm already worried about how much hotter
this year will be, haha.
As spring arrives, I imagine many people, like me, are looking at their lighter clothes and resolving to go on a diet.

To help you get a little closer
to that diet resolution,
today, we'll explore Wegovy, an obesity treatment that even Elon Musk reportedly chose.
What is Wegovy?
It is an injectable medication
for obesity treatment and weight management,
with semaglutide as its main ingredient,
a GLP-1 receptor agonist
approved by the U.S. Food and Drug Administration (FDA).

It comes as a single pen
with a 4-week supply for once-weekly use,
and the dosage is adjusted from an initial 0.25mg up to 2.4mg after consultation with a medical professional.
Wegovy has shown excellent weight loss effects
in clinical trials
and has received favorable reviews from users,
gaining a positive response in Korea as well.

At our Cheongdam Wegovy prescription clinic,
among the patients who visit,
Wegovy is prescribed after consultation for those with a BMI of 30kg/m² or higher, or a BMI between 27kg/m² and 30kg/m² with weight-related conditions such as high blood pressure or diabetes.
The main effects of Wegovy
are as follows:
Appetite suppression (Wegovy's semaglutide component acts on the brain's appetite center to reduce appetite.)
Delayed gastric emptying (Keeps food in the stomach longer, prolonging the feeling of fullness.)
Blood sugar control (Semaglutide stimulates insulin secretion and suppresses glucagon secretion, helping to stabilize blood sugar levels.)

When comparing it to
Saxenda, which was previously
a prominent obesity treatment,
Saxenda is injected once daily,
while Wegovy is injected once weekly.
The main ingredients are
liraglutide for Saxenda
and semaglutide for Wegovy,
indicating a difference in injection convenience.
Clinical trial results
also show that the weight loss effect
for Saxenda is a 5-10% reduction from baseline weight,
while for Wegovy, it's a 10-15% reduction from baseline weight,
confirming a slightly higher
weight loss effect.

However, when receiving a Wegovy prescription,
it is advisable to consult with the Cheongdam Wegovy prescription clinic again
to confirm the potential
side effects before getting the prescription.
The side effects of Wegovy include the following:
Gastrointestinal symptoms: Nausea, vomiting, diarrhea, constipation
Hypoglycemia: Primarily occurs in patients with type 2 diabetes
Pancreatitis: Rarely occurs, but if related symptoms appear, immediate consultation with a medical professional is necessary
Palpitations: Increased heart rate has been reported in some patients

Wegovy is
an obesity treatment that helps patients lose weight safely and effectively.
At our Cheongdam Wegovy prescription clinic,
for patients considering Wegovy treatment,
we are holding a spring event
to provide stable obesity treatment
with a dosage tailored to the patient's weight and condition
through thorough consultation with our medical staff.

Today, we learned about Wegovy, an injectable medication effective for weight loss.
If you have any more questions about the Cheongdam Wegovy prescription clinic's
spring event or Wegovy,
please call us anytime.
We will provide a kind consultation.
Thank you!^^
#WegovyPrescription #WegovyPrescriptionClinic #CheongdamWegovyPrescriptionClinic #Goldendiamant #WegovyPrice #WegovyEvent